Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Greater fish consumption tied to lower cerebrovascular disease risk
Eating more fish appeared linked to lower cerebrovascular disease risk, particularly among individuals younger than 75 years, according to results of a population-based study published in Neurology.
Revised criteria shorten time to MS diagnosis
The 2017 McDonald criteria shortened time to diagnosis of MS compared with the 2010 McDonald criteria, according to study results published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Dozens of countries promise to lower carbon intensity of health systems
Forty-seven countries, including the United States, have committed to developing climate-resilient and low-carbon health systems. They announced their efforts during the UN Climate Change Conference in Glasgow, also known as COP26.
Vitamin D, omega-3 supplements reduced risk for incident autoimmune disease
The use of vitamin D3 or omega-3 fatty acid supplements over a 5-year period may reduce the incidence of autoimmune disease in older adults by 25% to 30%, according to data presented at ACR Convergence 2021.
Researchers report dose-response association for physical activity, all-cause PD mortality
Physical activity and all-cause mortality in Parkinson’s disease may have a dose-response association, according to results of a nationwide population-based cohort study published in JAMA Neurology.
FDA OKs trial to test stroke treatment in distal brain regions
The FDA has granted investigational device exemption approval to Rapid Medical for a trial to expand stroke treatment to distal brain regions, according to a press release.
Town Hall: Booster Shots
In this episode, Joel M. Gelfand, MD, MSCE, and Leonard H. Calabrese, DO, are joined by Carlos del Rio, MD, as they discuss the use of booster shots in the general population and in patients with underlying autoimmunity.
Commentary: We must act now to make medicines affordable
We have a once-in-a-generation opportunity to make medicines affordable for our patients and support the health needs of every family in our nation. As physicians, now is the time to elevate the voices of our patients and act.
Health worse in patients concerned about developing drug-induced movement disorders
Patients from community mental health centers who expressed concerns about developing drug-induced movement disorders tended to report worse health and daily functioning, according to study results presented at NEI Congress.
Cost-effectiveness estimates for Alzheimer’s drugs should consider effects on caregivers
Estimating treatment effects on caregivers can help determine the cost-effectiveness of treatments for Alzheimer’s disease, according to results of an economic evaluation published in JAMA Network Open.
-
Headline News
Cooking, stove use among potential household health hazards for women
October 03, 20244 min read -
Headline News
FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening
October 04, 20241 min read -
Headline News
BLOG: Selling your practice when you own the real estate
October 04, 20243 min read
-
Headline News
Cooking, stove use among potential household health hazards for women
October 03, 20244 min read -
Headline News
FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening
October 04, 20241 min read -
Headline News
BLOG: Selling your practice when you own the real estate
October 04, 20243 min read